Another Core Product of TEDA-based Century Healthcare Enters Clinical Use

Recently, the Single-Use Intraocular Lens Injector Tip independently developed by Tianjin Century Healthcare Biomedical Engineering Co., Ltd., a company located in Tianjin Economic-Technological Development Area (TEDA), has been put into clinical use. Approved for market sales in February, this product is currently the only such approved product in Tianjin, and one of only four enterprises nationwide whose similar products have received market approval. Leveraging the company's proprietary patented technologies, this product has successfully resolved multiple bottlenecks of traditional surgical instruments, ensuring both safety and efficiency for intraocular lens implantation surgeries. Such product solidifies the company’s industry-leading edge in innovation.

Tianjin Century Healthcare, located in TEDA, is a Class III high-end medical device manufacturer engaging in R&D, production and sales. The company operates a 10,000-class clean production workshop, laboratories, and supporting systems. Its product portfolio covers intraocular lenses, vision care field products, and biological materials such as collagen. The company has been successively recognized as a National High-Tech Enterprise, a specialized and sophisticated SME that produce novel and unique products, and possesses the Key Laboratory of Innovative Ophthalmic Optical Technology in Tianjin.